Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
125272631	12527263	1	I	20150213	20160629	20160705	20160705	EXP		IT-VIIV HEALTHCARE LIMITED-IT2016GSK095343	VIIV		49.64	YR		M	Y	0.00000		20160705		PH	IT	IT

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	CUM DOSE CHR	CUM DOSE UNIT	DECHAL	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM	DOSE FREQ
125272631	12527263	1	PS	EPIVIR	LAMIVUDINE	1	Oral	300 MG, QD	52800	MG		20564	300	MG	FILM-COATED TABLET	QD
125272631	12527263	2	SS	REYATAZ	ATAZANAVIR SULFATE	1	Oral	300 MG, QD	52800	MG		0	300	MG		QD
125272631	12527263	3	SS	NORVIR	RITONAVIR	1	Oral	100 MG, QD	17600	MG	U	0	100	MG		QD

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
125272631	12527263	1	HIV infection
125272631	12527263	2	HIV infection
125272631	12527263	3	HIV infection

Outcome of event

Event ID	CASEID	OUTC COD
125272631	12527263	OT

Reactions reported

Event ID	CASEID	DRUG REC ACT	PT
125272631	12527263		Fatigue
125272631	12527263		Hyperbilirubinaemia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT	END DT
125272631	12527263	1	20140821	20150213
125272631	12527263	2	20140821	20150213
125272631	12527263	3	20140821	20150213